New Andes virus isolate haplotype obtained during prospective close contacts follow-up of an Hantavirus cardiopulmonary syndrome fatal case, Chile
| dc.contributor.author | Aldo Barrera | |
| dc.contributor.author | Hade Ramos | |
| dc.contributor.author | Eugenia Fuentes-Luppichini | |
| dc.contributor.author | Constanza Martínez-Valdebenito | |
| dc.contributor.author | Javiera Pradenas | |
| dc.contributor.author | C. Rogers | |
| dc.contributor.author | Carlos Palma | |
| dc.contributor.author | Campillo Sáinz C | |
| dc.contributor.author | Maritza Navarrete | |
| dc.contributor.author | Nicole Le Corre | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T19:45:06Z | |
| dc.date.available | 2026-03-22T19:45:06Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Andes virus (ANDV) is a zoonotic orthohantavirus that causes hantavirus cardiopulmonary syndrome. Transmission occurs mainly through contact with infected rodent excreta and, less frequently, between humans. Viral isolation from human samples is rare; in Chile, only one strain (CHI-7913, 2002) has been reported. The limited number of isolates reflects the challenge of obtaining samples during early viremia before antibodies appear, and maintaining long-term production of infectious particles in culture. We investigated an asymptomatic case from a family cluster, sampled during early infection. The absence of anti-ANDV antibodies in sera was confirmed by ELISA. Blood fractions were used to infect Vero E6 cells for six weeks, with infectivity monitored by RT-qPCR and Immunofluorescence. We obtained a replication-stable isolate from the buffy-coat fraction, achieving high viral loads at early passages. Whole-genome sequencing revealed a novel haplotype with mutations that reverted during non-human cell culture adaptation. This isolate, designated CHI-Hu13724, represents a new human-derived ANDV strain first reported in over two decades in Chile. It provides a valuable tool to study viral replication, infectivity, and pathogenicity. | |
| dc.identifier.doi | 10.1016/j.crmicr.2025.100472 | |
| dc.identifier.uri | https://doi.org/10.1016/j.crmicr.2025.100472 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/77902 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Current Research in Microbial Sciences | |
| dc.source | Instituto de Salud Pública de Chile | |
| dc.subject | Virology | |
| dc.subject | Hantavirus | |
| dc.subject | Viremia | |
| dc.subject | Biology | |
| dc.subject | Vero cell | |
| dc.subject | Antibody | |
| dc.subject | Infectivity | |
| dc.subject | Virus | |
| dc.subject | Haplotype | |
| dc.subject | Transmission (telecommunications) | |
| dc.title | New Andes virus isolate haplotype obtained during prospective close contacts follow-up of an Hantavirus cardiopulmonary syndrome fatal case, Chile | |
| dc.type | article |